Eli Lilly and Company
2,6-diamino pyridine compounds

Abstract:

The present invention provides a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.